Thromboembolism during hormone therapy in Japanese women

Seminars in Thrombosis and Hemostasis

Volumn 31, Issue 3, 2005, Pages 272-280

  Adachi, Tomoko ^a,b,c   Sakamoto, Shoichi ^d  

^a Aiiku Hospital   (Japan)

^b Aiiku Maternal and Child Health Center   (Japan)

^c Japan Association of Obstetricians and Gynecologists   (Japan)

^d NONE

Author keywords

Hormone replacement therapy; Ischemic brain stroke; Myocardial infarction; Oral contraceptives; Venous thromboembolism

Indexed keywords

CHORIONIC GONADOTROPIN; DANAZOL; HUMAN MENOPAUSAL GONADOTROPIN; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

ADULT; AGING; ARTICLE; CEREBROVASCULAR ACCIDENT; DRUG MEGADOSE; FEMALE; HEART INFARCTION; HORMONAL THERAPY; HUMAN; JAPAN; LIFESTYLE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; OBESITY; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SMOKING; THROMBOEMBOLISM; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; ARTERIES; CHILD; CONTRACEPTIVES, ORAL; DISEASE-FREE SURVIVAL; FEMALE; HORMONE REPLACEMENT THERAPY; HOSPITALIZATION; HUMANS; INCIDENCE; JAPAN; QUESTIONNAIRES; RISK FACTORS; THROMBOEMBOLISM; VEINS;

EID: 21844442354     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-872431     Document Type: Article

References (24)

1. Anonymous. Report of the survey on men's and women's life and the consciousness. Joint research project by the Ministry of Health, Labor and Welfare, and the Japan Family Planning Association. 2002 ed. Tokyo: Japan Family Planning Association; 2003:59-61
2. Ouchi Y. Investigation on Japanese women's consciousness of hormone replacement therapy. The guideline of hormone replacement therapy in postmenopausal women for health promotion. Tokyo: Medical Review Commission; 2001:197-204
3. Maternal and child health statistics of Japan. Tokyo: Maternal and Child Health Division, Equal Employment, Children and Families Bureau, Ministry of Health, Labour and Welfare; 2002:77-78
4. Satoh A, Diamaru O, Magaki R, et al. Pulmonary thromboembolism that developed during an airplane flight "economy-class syndrome" [In Japanese]. Nihon Kokyuki Gakkai Zasshi 1998;36:524-530
5. th annual meeting of the Japan Society of Obstetrics and Gynecology; 2003
6. Royal College of General Practitioners. Contracaptives, verous thrombosis, and varicose veins. J R Coll Gen Pract 1978;192:393-399
7. Inman WHW, Vessey MP, Westerholm B, et al. Thromboembolic disease and the steroidal content of oral contraceptives. BMJ 1970;2:203-209
8. Royal College of General Practitioners. Incidence of arterial disease among oral contraceptive users. J R Coll Gen Pract 1983;33:75-82
9. Mann JI, Inman WHW. Oral contraceptives and death from myocardial infarction. BMJ 1975;2:245-248
10. Mishell DR Jr. Oral contraception: past, present, and future perspectives. Int J Fertil 1991;36(suppl):7-18
11. Kluft C, Lansink M. Effect of oral contraceptives on haemostasis variables. Thromb Haemost 1997;78:315-326
12. Henkens CMA, Bom VJJ, Seinen AJ, et al. Sensitivities to activated protein C: influence of oral contraceptives and sex. Thromb Haemost 1995;73:402-404
13. Olivieri O, Friso S, Manzato F, et al. Resistance to activated protein C in healthy women taking oral contraceptives. Br J Haematol 1995;91:465-470
14. Yasui T, Uemura H, Yoneda N, et al. Assessment of serum estrogen levels by RIA with HPLC during hormone replacement therapy. Nippon Sanka Fujinka Gakkai Zasshi 1995;47:655-661
15. Kouno S. Phase I study of estradiol TTS-multiple application test. J Clin Therapeutics Meds [Japanese] 1992;8:1819-1833
16. Mandel FP, Geola FL, Lu JKH, et al. Biologic effects of various doses of ethinylestradiol in postmenopausal women. Obstet Gynecol 1982;59:673-679
17. Ouchi Y. Difference of sex steroid hormone agents between hormone replacement therapy and oral contraceptives. The guideline of hormone replacement therapy in postmenopausal women for health promotion. Tokyo: Medical Review Commission; 2001:178-184
18. Dickey RP. Managing Contraceptive Pill Patient, 9th ed. New Orleans: Essential Medical Information Systems, Inc.; 1998: 142-149
19. Hirsh J, Fuster V. Guide to anticoagulant therapy. Part 1: heparin. American Heart Association. Circulation 1994;89: 1449-1468
20. Vessey MP, Mant DS, Yeates D. Oral contraceptives and venous thromboembolism: findings in a large prospective study. BMJ 1986;292:526-531
21. Farmer RDT, Preston TD. The risk of venous thromboembolism associated with low estrogen oral contraceptives. J Obstet Gynecol 1995;00:195-200
22. Farley TMM, Collins J, Schlesselman JJ. Hormonal contraception and risk of cardiovascular disease. An international perspective. Contraception 1998;57:211-230
23. Rossouw JE. Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333
24. The Guideline of Low-Dose Oral Contraceptive Use. Tokyo: Society of Japan Obstetrics and Gynecology, Shindantochiryousha; 1999